4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-24-000165
Chief Executive Officer sold 4,460 shares at $29.56 ($131,838)
From the SEC's structured data for this filing
Trades in this filing
Salzmann Peter · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-09 | Sale : show line 1 in the form | −4,460 | $29.56 | $131,838 | 1,003,884 | D |
| Open-market sales · 4,460 sh · avg $29.56 · $131,838 | ||||||
Loading xslF345X05/wk-form4_1728676955.xml…